Although somatic mutations in the extracellular or transmembrane domain of the neu gene (the rodent analogue of HER2) have been reported in preclinical models, human HER2-positive breast tumors consistently demonstrate overexpression of wild-type HER2 [23]. Here, ERBB2 is linked to breast neoplasm.